Cash flow EssilorLuxottica

Stocks

EL

FR0000121667

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-07-16 EDT			Pre-market 02:43:26
169.50 ^EUR	+0.77%		168.22	-0.75%

07-14	CAC 40 ends flat as US inflation cools
07-14	Goldman Sachs Downgrades EssilorLuxottica to Neutral, Reduces PT	MT

7df04.hDVqQTcGQw5nxHqEm0tJVWkKWIlubZ1oRCLnCWXk2nc.1E8yNGRSFjwqqiXG8ioZESRTPdE6PawSMlrXSyyugzjUfAYDBTE2Qi2VFQ

Published financial data: ESSILORLUXOTTICA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	19.82B	24.49B	25.4B	26.51B	28.49B
Total Revenues	19.82B	24.49B	25.4B	26.51B	28.49B
Cost of Goods Sold, Total	7.71B	9.12B	9.56B	9.93B	11.47B
Gross Profit	12.11B	15.37B	15.83B	16.57B	17.02B
Selling General & Admin Expenses, Total	9.03B	11.55B	12B	12.47B	12.9B
Stock-Based Compensation (IS)	-	-	-	-	-
R&D Expenses	579M	600M	593M	631M	664M
Other Operating Expenses	-5M	-6M	-21M	-5M	-22M
Other Operating Expenses, Total	9.6B	12.14B	12.57B	13.09B	13.55B
Operating Income	2.51B	3.23B	3.26B	3.48B	3.47B
Interest Expense, Total	-141M	-156M	-198M	-253M	-314M
Interest And Investment Income	30M	30M	87M	97M	96M
Net Interest Expenses	-111M	-126M	-111M	-156M	-218M
Income (Loss) On Equity Invest.	3M	6M	-1M	3M	-
Currency Exchange Gains (Loss)	-11M	12M	-7M	20M	69M
Other Non Operating Income (Expenses)	-7M	-19M	-23M	-24M	-36M
EBT, Excl. Unusual Items	2.38B	3.1B	3.12B	3.32B	3.29B
Restructuring Charges	-96M	-67M	-96M	-52M	-63M
Merger & Related Restructuring Charges	-65M	-11M	-	-13M	-12M
Gain (Loss) On Sale Of Investments	-	41M	12M	-	-
Gain (Loss) On Sale Of Assets	-2M	9M	-2M	-	-3M
Asset Writedown	-51M	-24M	-	-	-
Legal Settlements	-	-	-	-10M	-15M
Other Unusual Items	34M	-20M	-	42M	-
EBT, Incl. Unusual Items	2.2B	3.03B	3.04B	3.29B	3.2B
Income Tax Expense	587M	751M	609M	800M	752M
Earnings From Continuing Operations	1.61B	2.28B	2.43B	2.49B	2.44B
Net Income to Company	1.61B	2.28B	2.43B	2.49B	2.44B
Minority Interest	-150M	-128M	-137M	-132M	-128M
Net Income - (IS)	1.46B	2.15B	2.29B	2.36B	2.32B
Net Income to Common Incl Extra Items	1.46B	2.15B	2.29B	2.36B	2.32B
Net Income to Common Excl. Extra Items	1.46B	2.15B	2.29B	2.36B	2.32B
Per Share Items
Net EPS - Basic	3.33	4.87	5.11	5.2	5.04
Basic EPS - Continuing Operations	3.33	4.87	5.11	5.2	5.04
Basic Weighted Average Shares Outstanding	439M	442M	448M	454M	459M
Net EPS - Diluted	3.28	4.83	5.08	5.13	4.98
Diluted EPS - Continuing Operations	3.28	4.83	5.08	5.13	4.98
Diluted Weighted Average Shares Outstanding	445M	446M	451M	460M	465M
Normalized Basic EPS	3.05	4.1	4.05	4.29	4.2
Normalized Diluted EPS	3	4.06	4.02	4.23	4.15
Dividend Per Share	2.51	3.23	3.95	3.95	4
Payout Ratio	9.43	21.1	21.28	49.3	23.63
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	4.2B	5.23B	5.28B	5.56B	5.57B
EBITA	3.59B	4.53B	4.57B	4.78B	4.73B
EBIT	2.51B	3.23B	3.26B	3.48B	3.47B
EBITDAR	4.61B	5.78B	5.85B	6.14B	6.17B
Effective Tax Rate - (Ratio)	26.68	24.78	20.07	24.31	23.54
Total Current Taxes	783M	898M	811M	1.01B	900M
Total Deferred Taxes	-197M	-147M	-202M	-206M	-148M
Normalized Net Income	1.34B	1.81B	1.81B	1.95B	1.93B
Interest on Long-Term Debt	52M	69M	90M	112M	126M
Non-Cash Pension Expense	-20M	6M	11M	11M	17M
Supplemental Operating Expense Items
Advertising Expense	1.46B	1.79B	1.8B	1.82B	1.84B
Selling and Marketing Expenses	7.16B	9.5B	9.84B	10.34B	10.62B
General and Administrative Expenses	1.87B	2.05B	2.16B	2.13B	2.28B
Research And Development Expense From Footnotes	848M	871M	866M	899M	918M
Net Rental Expense, Total	403M	555M	572M	578M	600M
Imputed Operating Lease Interest Expense	36.5M	54.93M	75.94M	94.07M	109M
Imputed Operating Lease Depreciation	367M	500M	496M	484M	491M
Stock-Based Comp., COGS (Total)	2M	-	-	-	70M
Stock-Based Comp., S&M Exp. (Total)	1M	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	5M	-	-	-	-
Stock-Based Comp., Other (Total)	202M	206M	220M	214M	285M
Total Stock-Based Compensation	210M	206M	220M	214M	355M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	3.29B	1.96B	2.56B	2.25B	3.54B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	3.29B	1.96B	2.56B	2.25B	3.54B
Accounts Receivable, Total	2.39B	2.73B	2.97B	3.29B	3.67B
Other Receivables	560M	557M	578M	619M	511M
Total Receivables	2.95B	3.29B	3.55B	3.91B	4.18B
Inventory	2.44B	2.79B	2.75B	3.15B	3.54B
Prepaid Expenses	195M	213M	228M	281M	309M
Other Current Assets, Total	398M	390M	638M	443M	436M
Total Current Assets	9.28B	8.64B	9.72B	10.04B	12.01B
Gross Property Plant And Equipment	12.03B	13.16B	13.91B	15.54B	15.62B
Accumulated Depreciation	-4.89B	-5.41B	-5.66B	-6.36B	-6.58B
Net Property Plant And Equipment	7.14B	7.76B	8.25B	9.17B	9.04B
Long-term Investments	285M	391M	445M	823M	937M
Goodwill	29.41B	30.73B	30.26B	32B	31.01B
Other Intangibles, Total	12.29B	12.12B	11.01B	11.05B	9.75B
Accounts Receivable Long-Term	66M	128M	172M	194M	242M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	498M	408M	387M	391M	359M
Other Long-Term Assets, Total	457M	380M	268M	604M	538M
Total Assets	59.43B	60.56B	60.52B	64.26B	63.9B
Liabilities
Accounts Payable, Total	2.22B	2.3B	2.38B	2.66B	2.88B
Accrued Expenses, Total	1.98B	1.88B	1.94B	1.95B	2.06B
Short-term Borrowings	457M	50M	452M	908M	2.66B
Current Portion of Long-Term Debt	579M	1.11B	1.41B	1.59B	1.37B
Current Portion of Leases	837M	846M	841M	914M	906M
Current Income Taxes Payable	805M	229M	245M	231M	201M
Unearned Revenue Current, Total	-	222M	209M	232M	277M
Other Current Liabilities	2.06B	2.25B	2.26B	2.07B	1.8B
Total Current Liabilities	8.93B	8.89B	9.74B	10.56B	12.15B
Long-Term Debt	8.91B	7.86B	6.56B	7.07B	6.81B
Long-Term Leases	2.23B	2.34B	2.4B	2.73B	2.65B
Unearned Revenue Non Current	27M	27M	15M	21M	23M
Pension & Other Post Retirement Benefits	537M	431M	431M	455M	445M
Deferred Tax Liability Non Current	2.45B	2.38B	2.14B	2.04B	1.88B
Other Non Current Liabilities	338M	497M	341M	384M	438M
Total Liabilities	23.43B	22.41B	21.63B	23.26B	24.4B
Common Stock, Total	80M	81M	82M	82M	83M
Additional Paid In Capital	22.38B	23.07B	22.88B	23.54B	24.82B
Retained Earnings	12.71B	13.44B	15.38B	15.75B	16.06B
Treasury Stock	-231M	-360M	-312M	-172M	-25M
Comprehensive Income and Other	246M	1.23B	212M	1.17B	-2.06B
Total Common Equity	35.19B	37.46B	38.24B	40.38B	38.89B
Minority Interest	811M	692M	653M	626M	604M
Total Equity	36B	38.15B	38.89B	41B	39.49B
Total Liabilities And Equity	59.43B	60.56B	60.52B	64.26B	63.9B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	441M	445M	452M	457M	463M
ECS Total Common Shares Outstanding	441M	445M	452M	457M	463M
Book Value / Share	79.78	84.11	84.59	88.41	83.96
Tangible Book Value	-6.51B	-5.4B	-3.04B	-2.67B	-1.88B
Tangible Book Value Per Share	-14.77	-12.13	-6.73	-5.84	-4.05
Total Debt	13.02B	12.2B	11.66B	13.22B	14.4B
Net Debt	9.72B	10.24B	9.1B	10.96B	10.85B
Debt Equivalent of Unfunded Proj. Benefit Obligation	486M	431M	430M	455M	445M
Debt Equivalent Oper. Leases	3.22B	4.44B	4.58B	4.62B	4.8B
Minority Interest, Total (Incl. Fin. Div)	811M	692M	653M	626M	604M
Equity Method Investments, Total	91M	83M	81M	85M	88M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	676M	790M	780M	868M	938M
Inventories - Work In Process, Total	101M	110M	114M	137M	137M
Inventories - Finished Goods, Total	2.13B	2.37B	2.34B	2.7B	3.04B
Land - (BS)	3.19B	3.64B	3.85B	4.48B	4.5B
Buildings, Total	-	-	-	-	-
Machinery, Total	3.76B	4.17B	4.41B	4.93B	5.16B
Full Time Employees	150K	154K	151K	153K	156K
Accumulated Allowance for Doubtful Accounts (Supple)	220M	180M	166M	186M	180M
Order Backlog	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.46B	2.15B	2.29B	2.36B	2.32B
Depreciation & Amortization - CF	1.33B	1.62B	1.64B	1.75B	1.83B
Amortization of Goodwill and Intangible Assets - (CF)	1.09B	1.3B	1.3B	1.3B	1.26B
Depreciation & Amortization, Total	2.42B	2.92B	2.95B	3.05B	3.09B
(Gain) Loss From Sale Of Asset	2M	2M	4M	6M	1M
Asset Writedown & Restructuring Costs	42M	49M	25M	49M	23M
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	160M	191M	195M	162M	280M
Other Operating Activities, Total	130M	-176M	-172M	-54M	50M
Change In Accounts Receivable	-	-	-159M	-133M	133M
Change in Other Net Operating Assets	329M	-356M	-268M	-564M	-601M
Cash from Operations	4.54B	4.78B	4.86B	4.87B	5.29B
Capital Expenditure	-1.03B	-1.57B	-1.53B	-1.52B	-1.52B
Sale of Property, Plant, and Equipment	16M	17M	11M	10M	12M
Cash Acquisitions	-7.08B	-965M	-114M	-1.76B	-911M
Investment in Marketable and Equity Securities, Total	97M	-184M	-94M	-367M	-141M
Other Investing Activities, Total	-65M	85M	4M	12M	12M
Cash from Investing	-8.06B	-2.62B	-1.72B	-3.62B	-2.55B
Long-Term Debt Issued, Total	75M	-	438M	2.38B	2.5B
Total Debt Issued	75M	-	438M	2.38B	2.5B
Long-Term Debt Repaid, Total	-1.52B	-1.92B	-1.96B	-2.24B	-2.47B
Total Debt Repaid	-1.52B	-1.92B	-1.96B	-2.24B	-2.47B
Issuance of Common Stock	34M	37M	34M	35M	36M
Repurchase of Common Stock	-317M	-431M	-271M	-274M	-376M
Common Dividends Paid	-138M	-454M	-487M	-1.16B	-547M
Common & Preferred Stock Dividends Paid	-138M	-454M	-487M	-1.16B	-547M
Other Financing Activities, Total	-172M	-815M	-175M	-388M	-192M
Cash from Financing	-2.04B	-3.58B	-2.42B	-1.65B	-1.05B
Foreign Exchange Rate Adjustments	166M	83M	-114M	88M	-391M
Miscellaneous Cash Flow Adjustments	-	-1M	-	-	-
Net Change in Cash	-5.39B	-1.33B	598M	-307M	1.29B
Supplemental Items
Cash Income Tax Paid (Refund)	618M	940M	916M	982M	764M
Levered Free Cash Flow	3.98B	2.59B	3.23B	3.24B	3.28B
Unlevered Free Cash Flow	4.06B	2.69B	3.36B	3.4B	3.47B
Change In Net Working Capital	-898M	885M	318M	521M	616M
Net Debt Issued / Repaid	-1.45B	-1.92B	-1.53B	143M	25M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.8	3.37	3.37	3.49	3.39
Return on Total Capital	3.34	4.07	4.04	4.15	4.02
Return On Equity %	4.69	6.16	6.3	6.24	6.07
Return on Common Equity	4.34	5.93	6.05	6	5.84
Margin Analysis
Gross Profit Margin %	61.1	62.77	62.35	62.52	59.74
SG&A Margin	45.56	47.15	47.25	47.03	45.3
EBITDA Margin %	21.21	21.34	20.8	20.98	19.55
EBITA Margin %	18.12	18.5	17.98	18.04	16.61
EBIT Margin %	12.64	13.19	12.85	13.13	12.19
Income From Continuing Operations Margin %	8.14	9.31	9.55	9.4	8.57
Net Income Margin %	7.38	8.79	9.01	8.9	8.13
Net Avail. For Common Margin %	7.38	8.79	9.01	8.9	8.13
Normalized Net Income Margin	6.75	7.4	7.14	7.34	6.76
Levered Free Cash Flow Margin	20.06	10.58	12.73	12.21	11.51
Unlevered Free Cash Flow Margin	20.5	10.98	13.22	12.81	12.2
Asset Turnover
Asset Turnover	0.35	0.41	0.42	0.42	0.44
Fixed Assets Turnover	3.24	3.29	3.17	3.04	3.13
Receivables Turnover (Average Receivables)	8.86	9.57	8.91	8.47	8.19
Inventory Turnover (Average Inventory)	3.52	3.48	3.45	3.37	3.43
Short Term Liquidity
Current Ratio	1.04	0.97	1	0.95	0.99
Quick Ratio	0.7	0.59	0.63	0.58	0.64
Operating Cash Flow to Current Liabilities	0.51	0.54	0.5	0.46	0.44
Days Sales Outstanding (Average Receivables)	41.2	38.16	40.97	43.21	44.56
Days Outstanding Inventory (Average Inventory)	103.56	104.74	105.73	108.72	106.5
Average Days Payable Outstanding	90.57	87.07	89.66	89.2	85.24
Cash Conversion Cycle (Average Days)	54.18	55.83	57.04	62.73	65.81
Long Term Solvency
Total Debt/Equity	36.16	31.99	29.97	32.23	36.46
Total Debt / Total Capital	26.56	24.24	23.06	24.38	26.72
LT Debt/Equity	30.95	26.72	23.03	23.91	23.97
Long-Term Debt / Total Capital	22.73	20.25	17.72	18.08	17.56
Total Liabilities / Total Assets	39.43	37.01	35.74	36.2	38.19
EBIT / Interest Expense	17.77	20.71	16.48	13.76	11.06
EBITDA / Interest Expense	34.93	39.43	31.36	25.81	20.9
(EBITDA - Capex) / Interest Expense	27.62	29.35	23.63	19.79	16.04
Total Debt / EBITDA	2.64	1.98	1.88	2.02	2.19
Net Debt / EBITDA	1.97	1.67	1.47	1.68	1.65
Total Debt / (EBITDA - Capex)	3.34	2.67	2.49	2.64	2.86
Net Debt / (EBITDA - Capex)	2.5	2.24	1.94	2.19	2.15
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	37.36	23.58	3.68	4.38	7.48
Gross Profit, 1 Yr. Growth %	50.38	27.51	3.01	4.89	2.82
EBITDA, 1 Yr. Growth %	107.66	33.1	3.31	7.48	1.66
EBITA, 1 Yr. Growth %	144.85	35.16	3.4	7.17	0.74
EBIT, 1 Yr. Growth %	464.41	43.75	4.75	10.26	2.21
Earnings From Cont. Operations, 1 Yr. Growth %	982.55	42.68	6.4	2.68	-1.93
Net Income, 1 Yr. Growth %	1.62K	48.62	6.37	3.06	-1.87
Normalized Net Income, 1 Yr. Growth %	956.27	54.16	4.26	11.34	1.76
Diluted EPS Before Extra, 1 Yr. Growth %	1.63K	48.62	5.18	0.98	-2.92
Accounts Receivable, 1 Yr. Growth %	14.58	14.36	8.67	10.81	11.43
Inventory, 1 Yr. Growth %	26.68	14.07	-1.4	14.62	12.37
Net Property, Plant and Equip., 1 Yr. Growth %	39.99	8.63	6.37	11.17	-1.4
Total Assets, 1 Yr. Growth %	13.59	1.93	-0.06	6.18	-0.6
Tangible Book Value, 1 Yr. Growth %	1.45K	-18.65	-43.71	-12.27	-29.75
Common Equity, 1 Yr. Growth %	9.05	6.82	2.09	5.59	-3.68
Cash From Operations, 1 Yr. Growth %	53.91	5.24	1.63	0.27	8.56
Capital Expenditures, 1 Yr. Growth %	58.46	52.62	-2.61	-0.59	0.2
Levered Free Cash Flow, 1 Yr. Growth %	44.37	-31.65	28.35	2.21	2.46
Unlevered Free Cash Flow, 1 Yr. Growth %	43	-30.69	28.3	3.18	3.48
Dividend Per Share, 1 Yr. Growth %	12.56	28.69	22.29	0	1.27
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.76	30.29	13.19	4.03	5.92
Gross Profit, 2 Yr. CAGR %	6.6	38.17	14.6	3.84	3.78
EBITDA, 2 Yr. CAGR %	8.2	60.7	15.97	4.31	3.75
EBITA, 2 Yr. CAGR %	7.94	75.76	16.71	4.04	3
EBIT, 2 Yr. CAGR %	10.92	169.72	20.51	5.71	4.89
Earnings From Cont. Operations, 2 Yr. CAGR %	16.67	291.18	23.21	4.52	0.35
Net Income, 2 Yr. CAGR %	16.55	403.17	25.73	4.7	0.57
Normalized Net Income, 2 Yr. CAGR %	11.5	278.22	24.24	5.76	5.01
Diluted EPS Before Extra, 2 Yr. CAGR %	15.94	404.19	25.02	3.06	-0.99
Accounts Receivable, 2 Yr. CAGR %	-0.89	14.47	11.48	9.74	11.12
Inventory, 2 Yr. CAGR %	6.25	20.21	6.05	6.31	13.49
Net Property, Plant and Equip., 2 Yr. CAGR %	12.58	23.32	7.49	8.74	4.7
Total Assets, 2 Yr. CAGR %	6.31	7.59	0.93	3.01	2.75
Tangible Book Value, 2 Yr. CAGR %	235.71	258.18	-32.33	-29.73	-21.42
Common Equity, 2 Yr. CAGR %	0.56	7.74	4.43	3.83	0.85
Cash From Operations, 2 Yr. CAGR %	17.38	27.27	3.42	0.95	4.33
Capital Expenditures, 2 Yr. CAGR %	6.8	55.51	21.92	-1.6	-0.2
Levered Free Cash Flow, 2 Yr. CAGR %	83.06	-2.99	-7.65	13.36	1.74
Unlevered Free Cash Flow, 2 Yr. CAGR %	77.26	-2.72	-6.97	13.91	2.75
Dividend Per Share, 2 Yr. CAGR %	-	20.35	25.45	10.59	0.63
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	22.31	12.1	20.74	10.18	5.17
Gross Profit, 3 Yr. CAGR %	21.56	12.99	25.28	11.19	3.45
EBITDA, 3 Yr. CAGR %	22.83	13.34	37.67	12.3	2.9
EBITA, 3 Yr. CAGR %	23.18	13.7	46.02	12.55	2.33
EBIT, 3 Yr. CAGR %	18.34	16.61	94.42	15.71	3.69
Earnings From Cont. Operations, 3 Yr. CAGR %	11.94	24.38	153.46	15.95	2.33
Net Income, 3 Yr. CAGR %	10.54	25.95	199.74	17.67	2.46
Normalized Net Income, 3 Yr. CAGR %	18.23	18.97	142.85	18.3	3.47
Diluted EPS Before Extra, 3 Yr. CAGR %	-6.94	25.56	199.02	16.43	1.02
Accounts Receivable, 3 Yr. CAGR %	0.37	3.95	12.5	11.26	10.3
Inventory, 3 Yr. CAGR %	6.33	8.79	12.53	8.84	8.29
Net Property, Plant and Equip., 3 Yr. CAGR %	11.39	11.25	17.39	8.71	5.25
Total Assets, 3 Yr. CAGR %	7.08	4.82	4.98	2.65	1.8
Tangible Book Value, 3 Yr. CAGR %	36.49	110.63	93.28	-26.21	-29.69
Common Equity, 3 Yr. CAGR %	2.27	2.48	5.82	4.81	1.26
Cash From Operations, 3 Yr. CAGR %	24.43	13.18	18.07	2.36	3.42
Capital Expenditures, 3 Yr. CAGR %	13.2	20.3	33.05	13.9	-1.01
Levered Free Cash Flow, 3 Yr. CAGR %	20.78	29.75	5.51	-5.13	9.17
Unlevered Free Cash Flow, 3 Yr. CAGR %	20.37	27.64	5.72	-4.34	9.91
Dividend Per Share, 3 Yr. CAGR %	7.16	-	20.99	16.32	7.39
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	22.74	21.68	18.58	8.8	14.58
Gross Profit, 5 Yr. CAGR %	23.7	21.29	18.62	9.23	16.14
EBITDA, 5 Yr. CAGR %	19.66	18.74	18.42	9.15	22.44
EBITA, 5 Yr. CAGR %	19.24	18.94	18.9	9.17	26.4
EBIT, 5 Yr. CAGR %	14.49	14.06	16.63	11.31	50.89
Earnings From Cont. Operations, 5 Yr. CAGR %	12.88	16.95	16.1	16.02	74.96
Net Income, 5 Yr. CAGR %	12.47	15.65	16.15	16.98	93.65
Normalized Net Income, 5 Yr. CAGR %	14.2	12.87	17.51	12.58	72.37
Diluted EPS Before Extra, 5 Yr. CAGR %	-2.43	0.5	4.53	16.02	92.17
Accounts Receivable, 5 Yr. CAGR %	8.11	23.55	4.67	6.23	11.95
Inventory, 5 Yr. CAGR %	16.8	27.37	6.22	7.79	12.91
Net Property, Plant and Equip., 5 Yr. CAGR %	42.53	33.8	9.81	10.24	12.14
Total Assets, 5 Yr. CAGR %	35.18	43.18	4.57	4.09	4.08
Tangible Book Value, 5 Yr. CAGR %	37.45	41.44	3.48	35.77	34.85
Common Equity, 5 Yr. CAGR %	39.39	45.18	3.05	3.02	3.8
Cash From Operations, 5 Yr. CAGR %	30.65	24.44	15.56	8.12	12.37
Capital Expenditures, 5 Yr. CAGR %	28.5	18.81	16.61	11.01	18.6
Levered Free Cash Flow, 5 Yr. CAGR %	30.07	15.81	7.46	22.24	3.55
Unlevered Free Cash Flow, 5 Yr. CAGR %	29.58	15.61	7.58	21.3	4.11
Dividend Per Share, 5 Yr. CAGR %	10.85	16.12	14.13	-	12.4